University of Maryland receives $23 million for HIV vaccine

Friday, May 6, 2011 12:23 PM

Scientists at the University of Maryland School of Medicine will be able to move forward on decades-long work for a promising HIV/AIDS vaccine after receiving $23.4 million from a consortium led by The Bill & Melinda Gates Foundation, according to The Baltimore Sun.

The money was awarded to the university's Institute of Human Virology, headed by Dr. Robert Gallo, who helped discover the human immunodeficiency virus.   

The vaccine being researched would potentially neutralize different strains of HIV. The researchers say previous vaccine candidates responded only to single strains or narrow ranges of the disease.

The Bill & Melinda Gates Foundation donated $16.8 million to the research, while the Army's Military HIV Research Program provided $2.2 million. The National Institutes of Health and others also have contributed funds.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs